astrazeneca
Entity, reached from Hormuz.
- Evidence
- 143 documents · 49 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 5 May 2026, last seen 9 Oct 2026
- Measured
- 30% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- STAT News · 2026-10-07 · STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more (opens the source in a new tab)
- STAT News · 2026-10-07 · STAT+: AstraZeneca opens new Boston site (opens the source in a new tab)
- Endpoints News · 2026-10-03 · Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone (opens the source in a new tab)
- AllSci News · 2026-10-02 · AstraZeneca, Daiichi team with Summit to pair Datroway with ivonescimab in Phase III TNBC push (opens the source in a new tab)
- STAT News · 2026-09-30 · STAT+: AstraZeneca invests $2 billion in Summit Therapeutics (opens the source in a new tab)
- Fierce Pharma · 2026-09-30 · Hansoh’s Tagrisso rival loses EU approval after AstraZeneca legal challenge (opens the source in a new tab)
- AllSci News · 2026-09-30 · AstraZeneca wins Priority Review for Imfinzi-EV regimen in bladder cancer (opens the source in a new tab)
- AllSci News · 2026-09-30 · AstraZeneca seeks FDA approval for HutchMed's Orpathys plus Tagrisso in MET-driven lung cancer (opens the source in a new tab)
- AllSci News · 2026-09-30 · AstraZeneca invests USD 2b in Summit to advance ivonescimab-ADC combination trials (opens the source in a new tab)
- BioPharma Dive · 2026-09-30 · AstraZeneca invests $2B in Summit, gaining ‘seat at the table’ for PD-1/VEGF drug push (opens the source in a new tab)
1 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with fda (48 documents)seen together
- co-mentioned with novartis (42 documents)seen together
- co-mentioned with china (37 documents)seen together
- co-mentioned with roche (34 documents)seen together
- co-mentioned with eli lilly (33 documents)seen together
- co-mentioned with merck (33 documents)seen together
- co-mentioned with pfizer (32 documents)seen together
- co-mentioned with ai (29 documents)seen together
- co-mentioned with bristol myers squibb (28 documents)seen together
- co-mentioned with clinical trials (28 documents)seen together